You just read:

AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation

News provided by

Advanced Inhalation Therapies (AIT)

Jan 07, 2014, 10:22 ET